PMID: 15374526Jan 1, 1990Paper

Weight change, survival time and cause of death in Dutch elderly

Archives of Gerontology and Geriatrics
D J DeegJ D Curb

Abstract

Weight change, subsequent survival time and cause of death are reported from the Dutch Longitudinal Study among the Elderly. Data consist of a national sample of persons aged 65-99 years. Six hundred and fifty-eight subjects were examined in the baseline years 1955-1957 and were re-examined 5 years later. Vital status and cause of death were ascertained for 604 of these subjects through 1983. Those subjects who experienced a decline in body mass index (BMI, kg/m(2)) during the period of observation, were likely to be in poorer health and have a shorter survival time than those subjects with stable weight, regardless of initial BMI. Weight gain was associated with shorter survival time only in the age group 65-74 and in those with heart disease. Weight loss, on the other hand, was most likely to result in decreased survival time among those ultimately dying of stroke, pneumonia/influenza or heart disease. As such, weight loss may be an indicator of the severity of disease. The noted associations remained, even when those surviving less than two years were omitted from the analyses. Thus, in longer survivors, weight loss may be associated with decreased vitality and decreased ability to survive once a disease becomes apparent.

References

Jan 1, 1979·Journal of Chronic Diseases·E A Lew, L Garfinkel
Jan 1, 1989·Journal of Clinical Epidemiology·M C WhiteD W Merrill
Jan 1, 1989·Journal of Clinical Epidemiology·D J DeegP J van der Maas
Jan 1, 1989·Journal of Clinical Epidemiology·A RissanenJ Maatela
May 1, 1987·Journal of Gerontology·J T DwyerP Sullivan
Jan 16, 1987·JAMA : the Journal of the American Medical Association·J E MansonW C Willett
Mar 1, 1987·American Journal of Public Health·S SidneyA B Siegelaub
Dec 1, 1985·Annals of Internal Medicine·R J Garrison, W P Castelli
Nov 1, 1972·Annals of Internal Medicine·G A BrayE J Drenick
Jul 1, 1967·British Journal of Preventive & Social Medicine·T Khosla, C R Lowe
Aug 21, 1982·British Medical Journal·R J JarrettG Rose
Nov 1, 1981·Annals of Internal Medicine·K I MartonJ R Krupp
May 9, 1980·JAMA : the Journal of the American Medical Association·P SorlieW B Kannel
Jan 1, 1961·American Journal of Public Health and the Nation's Health

❮ Previous
Next ❯

Citations

May 1, 1995·Archives of Gerontology and Geriatrics·B LjungquistB Steen
Jan 1, 1996·Archives of Gerontology and Geriatrics·M V BaldelliJ M Pradelli
Aug 1, 1996·Journal of Clinical Epidemiology·K S BleschT P Miles
Aug 13, 2002·Journal of the American Dietetic Association·Hélène PayetteKatherine Gray-Donald
Jul 10, 2003·Archives of Gerontology and Geriatrics·Olga AugustssonBertil Steen
Nov 16, 2012·International Psychogeriatrics·Brian D PowerOsvaldo P Almeida
Nov 29, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Dawn E AlleyTamara B Harris
Dec 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·Magdalena LeszczynieckaPaul B Fisher
May 1, 2007·Journal of the American Dietetic Association·Claire A ZizzaMark Lino
Mar 5, 2013·Journal of the American Geriatrics Society·Anna K DahlDenis Gerstof
Oct 21, 2011·ISRN Nursing·Kjell KrügerAnders Grimsmo
Dec 11, 1999·Journal of the American Geriatrics Society·M W ReynoldsJ Magaziner
Sep 13, 2006·Archives of Neurology·David K JohnsonJohn C Morris
Jan 5, 2006·Canadian Journal of Physiology and Pharmacology·Hélène Payette
Nov 1, 1995·The Proceedings of the Nutrition Society·W A van StaverenC de Graaf
Apr 1, 1996·Nutrition Reviews·I M Lee, R S Paffenbarger

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.